Cargando...
PATH-08. THE PROGNOSTIC VALUE OF A NOVEL QUANTITATIVE MGMT PROMOTER METHYLATION SCORE FOR PATIENTS WITH GLIOBLASTOMA
BACKGROUND: Methylation status of the O 6-methylguanine–DNA methyltransferase (MGMT) gene promoter is a well-known prognostic marker in glioblastoma, with prior studies demonstrating that methylated MGMT promoter corresponds to increased overall survival (OS) and progression free survival (PFS). MGM...
Gardado en:
| Publicado en: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692076/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.699 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|